4 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
An update on therapeutic opportunities offered by cancer glycolytic metabolism.
Universit£
Prodrugs of a 1-Hydroxy-2-oxopiperidin-3-yl Phosphonate Enolase Inhibitor for the Treatment of
University Of Texas Md Anderson Cancer Center
Bioreducible Phosphonoamidate Pro-drug Inhibitor of Enolase: Proof of Concept Study.
University Of Texas Md Anderson Cancer Center